NCT05102851|Completed
Impact of Prediabetes on Acute Coronary Syndrome
Impact of Prediabetes On Acute Coronary Syndrome in Sohag University Hospital
Loading search results
Impact of Prediabetes On Acute Coronary Syndrome in Sohag University Hospital
Sponsor study identifier
observational
100
1 country
1
Study Start
August 1, 2021
Actual (reported)Primary Completion
August 1, 2022
Actual (reported)Study Completion
August 23, 2022
Actual (reported)Diabetes mellitus is one of the chronic non-communicable diseases which have emerged as a leading global health problem. According to the International Diabetes Federation Atlas guideline report, currently, there are 352 million adults with impaired glucose tolerance who are at high risk of developing diabetes in the future. In 2017, it was estimated that 425 million people (20-79 years of age) suffered from Diabetes mellitus, and the number is expected to rise to 629 million by 2045. Moreover, Egypt is considered one of the top 10 countries in the world
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 23, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 1, 2021
Actual (reported)August 18, 2021
Actual (reported)November 2, 2021
Actual (reported)August 1, 2022
Actual (reported)August 23, 2022
Actual (reported)Hba1c
We consider patients with Hba1c less than 5.7% not diabetic , Patients with Hba1c from 5.7%-6.4% prediabetic and patients with Hba1c 6.5% or more diabetic patients
Day 1
CCU admission
All patients admitted with acute coronary syndrome will be included in the research
6 months
All patients with the acute coronary syndrome were included in the study. Pre-diabetic patient. Non-diabetic patient(Controlled)
Full history: age, sex, smoking, known diabetes, positive family history high serum creatinine, history of prior percutaneous coronary intervention (PCI) or coronary arteries bypass grafting (CABG), or acute coronary syndrome (ACS). hypertension, diet.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Statistical presentation and analysis of the present study will be conducted SPSS V.22. Data will be expressed into phases: Ι- Descriptive Mean value(X) and Standard Deviation (SD): for quantitative data. Frequency and percentage for qualitative data. Π- Analytic by t-student test and Chi-square test. P value \>0.05 will be considered statistically non-significant. P value ≤0.05 will be considered statistically significant. P value ≤0.001 will be considered statistically highly significant. Variance: Correlation of MPV with other parameters was performed by Pearson correlation test (r value as the coefficient).
Sohag University
Sohag, 82524, Egypt
Amal K. Ahmed, Ass. Prof.
Sohag University
Hany A. Muhammed Khalil, Lecturer
Sohag University
100 participants (actual enrollment reported by the registry).
First Submitted
August 18, 2021
First Posted
November 2, 2021
Study Start
August 1, 2021
Actual (reported)Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
Contact the study team to confirm eligibility.
Primary Completion
August 1, 2022
Actual (reported)Study Completion
August 23, 2022
Actual (reported)Last Updated
August 31, 2022
Record last verified: 2021-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: